NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

111 Inc (NASDAQ: YI)

 
YI Technical Analysis
5
As on 13th Feb 2025 YI STOCK Price closed @ 7.35 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.63 & Strong Buy for SHORT-TERM with Stoploss of 2.48 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

YISTOCK Price

Open 7.04 Change Price %
High 7.48 1 Day -0.01 -0.14
Low 7.04 1 Week 0.87 13.43
Close 7.35 1 Month 6.70 1030.77
Volume 25665 1 Year 4.56 163.44
52 Week High 7.18 | 52 Week Low 0.43
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
INTC 24.13 7.34%
NVDA 135.29 3.16%
ADTX 0.07 -22.22%
PRPH 0.34 21.43%
LCID 3.26 13.59%
LMDX 0.02 0.00%
EDSA 3.25 74.73%
DGLY 0.09 -43.75%
SMCI 42.28 6.55%
 
NASDAQ USA Top Gainers Stocks
TANH 3.83 4687.50%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
HYFM 6.40 1085.19%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
ZVZZT 63.98 509.33%
MBRX 1.27 202.38%
NDRAW 0.03 200.00%
HYMCL 0.05 150.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
LILM 0.05 -79.17%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
TFFP 0.06 -62.50%
MILEW 0.06 -53.85%
LOTZW 0.01 -50.00%
BTAQW 0.01 -50.00%
 
 
YI
Daily Charts
YI
Intraday Charts
Whats New @
Bazaartrend
YI
Free Analysis
 
YI Important Levels Intraday
RESISTANCE8.20
RESISTANCE7.93
RESISTANCE7.76
RESISTANCE7.59
SUPPORT7.11
SUPPORT6.94
SUPPORT6.77
SUPPORT6.50
 
YI Forecast February 2025
4th UP Forecast8.49
3rd UP Forecast8.12
2nd UP Forecast7.9
1st UP Forecast7.67
1st DOWN Forecast7.03
2nd DOWN Forecast6.8
3rd DOWN Forecast6.58
4th DOWN Forecast6.21
 
YI Weekly Forecast
4th UP Forecast7.95
3rd UP Forecast7.76
2nd UP Forecast7.64
1st UP Forecast7.52
1st DOWN Forecast7.18
2nd DOWN Forecast7.06
3rd DOWN Forecast6.94
4th DOWN Forecast6.75
 
YI Forecast2025
4th UP Forecast21.07
3rd UP Forecast16.67
2nd UP Forecast13.95
1st UP Forecast11.23
1st DOWN Forecast3.47
2nd DOWN Forecast0.75
3rd DOWN Forecast-1.97
4th DOWN Forecast-6.37
 
 
YI Other Details
Segment EQ
Market Capital 441715200.00
Sector Healthcare
Industry Pharmaceutical Retailers
Offical website >
 
YI Address
YI
 
YI Latest News
 
Your Comments and Response on 111 Inc
 
YI Business Profile
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd.; BeiGene, Ltd.; Jianming Pharmaceutical Group; and Chugai Pharma China Co., Ltd. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China. Address: No. 295 ZuChongZhi Road, Shanghai, China, 201203
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service